Specification and Implementation of Decision Analytic Model Structures for Economic Evaluation of Health Care Technologies

Research output: Chapter in Book/Report/Conference proceedingEntry for encyclopedia/dictionary

2 Citations (Scopus)

Abstract

Introduction
In countries such as Australia, the UK, and Canada, public funding decisions for health technologies (e.g., pharmaceuticals) are based predominantly on cost-effectiveness data. National reimbursement bodies in these countries, such as the Pharmaceutical Benefits Advisory Committee in Australia and National Institute for Health and Clinical Excellence in the UK,provide guidance to the government, which form the basis of decisions around public funding of new health technologies.Most often, this process involves using decision analytic models to inform reimbursement approval at the national level.
Original languageEnglish
Title of host publicationEncyclopedia of Health Economics
EditorsAnthony Culyer
PublisherElsevier
Chapter01401
Pages340-347
Number of pages8
ISBN (Electronic)9780123756787
ISBN (Print)978-0-12-375679-4
DOIs
Publication statusPublished - 2014
Externally publishedYes

Keywords

  • Healthcare technologies
  • economic evaluation
  • decision analytic model

Fingerprint Dive into the research topics of 'Specification and Implementation of Decision Analytic Model Structures for Economic Evaluation of Health Care Technologies'. Together they form a unique fingerprint.

  • Cite this